GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Noul Co Ltd (XKRX:376930) » Definitions » Net Cash per Share

Noul Co (XKRX:376930) Net Cash per Share : ₩190.11 (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Noul Co Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Noul Co's Net Cash per Share for the quarter that ended in Dec. 2023 was ₩190.11.

The historical rank and industry rank for Noul Co's Net Cash per Share or its related term are showing as below:

XKRX:376930' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 12.21   Med: 21.36   Max: 21.36
Current: 13.31

During the past 5 years, the highest Price-to-Net-Cash Ratio of Noul Co was 21.36. The lowest was 12.21. And the median was 21.36.

XKRX:376930's Price-to-Net-Cash is ranked worse than
72.15% of 79 companies
in the Medical Diagnostics & Research industry
Industry Median: 7.31 vs XKRX:376930: 13.31

Noul Co Net Cash per Share Historical Data

The historical data trend for Noul Co's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noul Co Net Cash per Share Chart

Noul Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
-1.45 -1,472.64 -445.23 -174.58 190.11

Noul Co Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -174.58 -344.75 -475.29 332.09 190.11

Competitive Comparison of Noul Co's Net Cash per Share

For the Diagnostics & Research subindustry, Noul Co's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Noul Co's Price-to-Net-Cash Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Noul Co's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Noul Co's Price-to-Net-Cash falls into.



Noul Co Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Noul Co's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(19612.044-12587.913-0)/36.9471
=190.11

Noul Co's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(19612.044-12587.913-0)/36.9471
=190.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noul Co  (XKRX:376930) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Noul Co Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Noul Co's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Noul Co (XKRX:376930) Business Description

Traded in Other Exchanges
N/A
Address
B-10F, 338, Gwanggyojungang-ro, Suji-gu, Gyeonggi-do, Yongin-si, KOR, 16942
Noul Co Ltd provides solutions for chronic and systemic problems in healthcare. The company's miLab is an all-in-one, fully-automated device which can process sample preparation and AI diagnostic in one workflow. It integrates technologies from computer vision AI, bio, hardware, and software engineering.

Noul Co (XKRX:376930) Headlines

No Headlines